The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Size Is Forecasted For The Intravenous Infusion Pumps Market By 2030 Based On Its 2026 Value?
The intravenous infusion pumps market has demonstrated significant expansion in recent years. This market is set to expand from $6.37 billion in 2025 to $6.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The historical growth trajectory can be attributed to several factors, including the enlargement of hospital infrastructure, a greater reliance on intravenous drug delivery, the increasing occurrence of chronic diseases, the integration of programmable infusion systems, and enhancements in the accuracy and reliability of these pumps.
The intravenous infusion pumps market is anticipated to experience substantial growth in the upcoming years, with its value projected to reach $9.98 billion by 2030, progressing at a compound annual growth rate (CAGR) of 9.4%. This expansion during the forecast period is driven by factors such as an increasing need for interoperable infusion devices, a heightened emphasis on patient-centric care approaches, the expansion of remote patient monitoring, growing investments in smart healthcare infrastructure, and the rising adoption of home-based infusion therapies. Noteworthy trends during this period are expected to include the increasing adoption of smart infusion pumps, the greater use of dose error reduction software, the growing integration of connected hospital systems, the widening availability of ambulatory and home infusion therapies, and an enhanced focus on medication safety.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3305&type=smp
What Are The Main Drivers Accelerating The Growth Of The Intravenous Infusion Pumps Market?
The expanding occurrence of bleeding conditions is anticipated to fuel the expansion of the intravenous infusion pump market. These disorders encompass a range of medical ailments that hinder the body’s ability to form blood clots effectively. The increasing incidence of bleeding disorders stems from genetic elements and a rise in marriages between relatives, which heightens the likelihood of inherited clotting problems within populations. Intravenous infusion pumps serve as an essential therapeutic instrument for bleeding issues, employed to administer necessary medications with precision and regulation, thereby ensuring patients get the precise dosage at the appropriate moment. For example, data from April 2025, provided by Pfizer, a US-based biopharmaceutical company, indicated that over 11,800 individuals were affected by haemophilia A or B in the United Kingdom between 2023 and 2024, with the disorder impacting more than 800,000 people worldwide and typically identified during early childhood. Consequently, the growing occurrence of bleeding conditions is propelling the expansion of the intravenous infusion pump market in the future.
Which Segment-Based Categories Are Covered In The Intravenous Infusion Pumps Market?
The intravenous infusion pumps market covered in this report is segmented –
1) By Product: Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Other Products
2) By Application: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Specialty Clinics, Other End Users
Subsegments:
1) By Volumetric: Large-volume Pumps, Small-volume Pumps
2) By Syringe: Micro Syringe Pumps, Macro Syringe Pumps
3) By Enteral: Portable Enteral Pumps, Stationary Enteral Pumps
4) By Ambulatory: Patient-controlled Analgesia (PCA) Pumps, Insulin Pumps, Disposable Pumps
5) By IV Disposables: IV Tubing Sets, IV Catheters, IV Cannulas, IV Solutions
6) By Other Products: Implantable Pumps, Smart Pumps, Elastomeric Pumps
Which Trends Are Supporting The Evolution Of The Intravenous Infusion Pumps Market?
Leading companies within the intravenous infusion pumps market are concentrating on technological advancements, such as real-time flow monitoring systems, to dynamically detect and correct deviations in infusion rates, thereby enhancing accuracy and patient safety. These real-time flow monitoring systems are sophisticated medical devices designed to continuously measure and track the flow rate of fluids, including medication or blood, in real time, ensuring precise and timely delivery during treatment. For instance, in February 2023, Mindray, a China-based manufacturer of high-tech medical devices, introduced its BeneFusion I-/U Series infusion systems. These systems incorporate Smart Accurate™ technology, which continuously monitors the actual drug flow rate and provides real-time feedback to correct deviations. The pumps also feature sleek, intuitive UIs with full-touch screens, a customizable drug library, and a patented BolusGUARD motorized syringe loading system designed to prevent unintentional boluses during loading. Additionally, they support connectivity through Mindray’s M-IoT system for centralized device management, maintenance analytics, and drug library updates, reinforcing safety and efficiency across hospital networks.
Which Industry Players Are Present In The Intravenous Infusion Pumps Market?
Major companies operating in the intravenous infusion pumps market are B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation
Access The Complete Intravenous Infusion Pumps Market Report:
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Which Region Has The Strongest Presence In The Intravenous Infusion Pumps Market?
North America was the largest region in the intravenous infusion pumps market in 2025. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Intravenous Infusion Pumps Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Browse Through More Reports Similar to the Global Intravenous Infusion Pumps Market 2026, By The Business Research Company
Intravenous Infusion Pumps Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Intravenous Immunoglobulin Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
Microfluidics Market Report 2026
https://www.thebusinessresearchcompany.com/report/microfluidics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model